Angiolab, Inc. (XKON:251280)

Angiolab Statistics

Total Valuation

Angiolab has a market cap or net worth of KRW 12.80 billion.

Market Cap	12.80B
Enterprise Value	n/a

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

Angiolab has 3.28 million shares outstanding.

Current Share Class	3.28M
Shares Outstanding	3.28M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	4.87%
Float	3.07M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	18.21
PB Ratio	3.60
P/TBV Ratio	4.35
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.72

Current Ratio	6.72
Quick Ratio	6.05
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-775.80

Financial Efficiency

Return on equity (ROE) is -28.58% and return on invested capital (ROIC) is -10.05%.

Return on Equity (ROE)	-28.58%
Return on Assets (ROA)	-8.55%
Return on Invested Capital (ROIC)	-10.05%
Return on Capital Employed (ROCE)	-18.00%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.13
Inventory Turnover	1.29

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -39.55% in the last 52 weeks. The beta is 0.03, so Angiolab's price volatility has been lower than the market average.

Beta (5Y)	0.03
52-Week Price Change	-39.55%
50-Day Moving Average	4,062.90
200-Day Moving Average	5,522.40
Relative Strength Index (RSI)	42.69
Average Volume (20 Days)	849

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Angiolab had revenue of KRW 702.62 million and -1.19 billion in losses. Loss per share was -1,356.00.

Revenue	702.62M
Gross Profit	338.60M
Operating Income	-716.07M
Pretax Income	-1.19B
Net Income	-1.19B
EBITDA	-483.63M
EBIT	-716.07M
Loss Per Share	-1,356.00

Balance Sheet

The company has 2.49 billion in cash and n/a in debt, giving a net cash position of 2.49 billion or 757.45 per share.

Cash & Cash Equivalents	2.49B
Total Debt	n/a
Net Cash	2.49B
Net Cash Per Share	757.45
Equity (Book Value)	3.56B
Book Value Per Share	3,675.78
Working Capital	2.40B

Cash Flow

In the last 12 months, operating cash flow was -82.73 million and capital expenditures -22.57 million, giving a free cash flow of -105.30 million.

Operating Cash Flow	-82.73M
Capital Expenditures	-22.57M
Free Cash Flow	-105.30M
FCF Per Share	-32.09

Margins

Gross margin is 48.19%, with operating and profit margins of -101.91% and -168.87%.

Gross Margin	48.19%
Operating Margin	-101.91%
Pretax Margin	-168.87%
Profit Margin	-168.87%
EBITDA Margin	-68.83%
EBIT Margin	-101.91%
FCF Margin	n/a

Dividends & Yields

Angiolab does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-9.27%
FCF Yield	-0.82%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Angiolab has an Altman Z-Score of -0.27 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.27
Piotroski F-Score	1